Background. Acute cardiac and cerebrovascular accidents are more frequent in hypertensive subjects with a family history of acute vascular accidents. The mechanisms underlying the susceptibility to vascular disease in these subjects are unknown. We investigated whether a parental history of premature heart attack or stroke in hypertensive subjects is associated with abnormalities of sodium handling.
more likely that patients with borderline or mild hypertension will progress to a more severe stage than individuals with a negative family history living under similar environmental circumstances.2 That genetic factors may contribute to the pathogenesis of vascular accidents in hypertension is also suggested by the fact that a strain of stroke-prone spontaneously hypertensive rats (SHR) was established by successive selective inbreeding among the sublines of SHR. 3 The pathophysiological abnormalities through which genetic factors eventually lead to the development of vascular complications in experimental as well as human essential hypertension are unknown.
Experimental observations demonstrate that salt intake may accelerate the development of vascular lesions in genetic models of hypertension such as Dahl salt-sensitive rats4 and stroke-prone SHR. 5 In this latter model the harmful effect of salt is related to inadequate modulation of the renin-angiotensin system.67 These findings are consistent with the positive correlation between plasma renin activity (PRA) and the development of heart attack and stroke that has been reported in hypertensive subjects. 8, 9 We investigated whether in human hypertension a familial history of cardiovascular accidents is associated with abnormalities of salt-regulating hormonal systems or sodium excretion. We compared the clinical, hemodynamic, and hormonal characteristics of patients with mild, uncomplicated essential hypertension and a positive family history of premature stroke or heart attack in one or both parents with those of age-matched patients with essential hypertension of comparable severity but a negative family history of cardiac or cerebrovascular accidents. We also assessed the dynamic adjustments of the salt-regulating hormones as well as the ability to excrete sodium in response to acute saline loading in the two subgroups of patients and in a control group of normal subjects.
Methods
The hypertensive patients included in the study were selected from a group of 150 consecutive patients evaluated for hypertension at our center. The study was performed in patients with mild, uncomplicated essential hypertension (18 men, 14 women) aged between 25 and 51 years. The selected patients had an outpatient diastolic blood pressure in excess of 90 mm Hg and below 109 mm Hg in the sitting position on at least three occasions documented for at least 3 months before the study. Patients older than 55 years or younger than 25 years were excluded. Other exclusion criteria were moderate or severe hypertension (diastolic blood pressure exceeding 109 mm Hg), secondary hypertension, obesity, renal failure, neoplastic or other major diseases, serum cholesterol levels exceeding 240 mg/dl, a personal history of ischemic brain or cardiac disease, and signs or symptoms of heart failure. The protocol was approved by the Human Subjects Committee of our institution. Written informed consent for the procedures was obtained from each patient before the study, after a full description of the protocol and purpose of the study had been given.
At their interviews, all patients answered standard questions concerning current cigarette smoking and personal history of heart attack, heart failure, stroke, or diabetes. A history of hypertension, heart attack, or stroke in the family was ascertained in each individual according to the methodology described by Hunt et al. 10 Prescribed antihypertensive medication was required for the patients to be defined as hypertensive. To avoid bias, the family history information was in all cases collected by individuals who were unaware of the purpose and results of the study. Among the patients who satisfied the inclusion criteria, 18 had at least one parent who experienced myocardial infarction or stroke" before age 55 years. These patients were defined as FV+. Fourteen patients had a family history completely negative for heart attack and stroke and were defined as FV-.
To define the normal range of the study parameters, eight normal volunteers (four men, four women) (blood pressure below 140/90 mm Hg) aged between 26 and 51 years and with a negative family history for hypertension and cardiovascular accidents underwent the same protocol. Protocol
All antihypertensive medications were discontinued for at least 4 weeks before the study. The subjects were admitted to the metabolic ward of our institution and were fed a constant isocaloric diet containing 140 meq sodium and 60 meq potassium for at least 1 week before the study. Fluid intake was maintained at 1,500 ml/day. Daily 24-hour urine collections were analyzed for sodium, potassium, albumin, and creatinine excretion. Blood pressure was measured according to the recommendations of the American Heart Association.'2 Evaluation of each subject included careful physical examination (including eye fundus), assessment of body weight and height, 12-lead electrocardiogram, one-and twodimensional echocardiogram, forearm vascular compliance, and serum creatinine and fasting glucose, total cholesterol, and high density lipoprotein (HDL)-cholesterol concentrations.
The study was performed after the subjects had achieved metabolic balance, as determined by 24 30 -minute intervals throughout the study. All measurements were repeated again 60 minutes after withdrawal of the saline load.
Laboratory Methods
All blood samples were collected on ice and spun within 10 minutes; the plasma was then separated and frozen until the time of assay, which did not exceed 4 weeks.
PRA was measured by radioimmunoassay according to the method described by Menard and Catt13 (sensitivity: 50 pg/tube angiotensin I; intra-assay and interassay coefficients of variation: 6% and 10%, respectively). ANF levels were determined by radioimmunoassay as previously described by our laboratory'4 by using rabbit antiserum ( calculate the arterial volume and was estimated by means of transcutaneous Doppler velocimetry operating at a frequency of 8 MHz and pulsating at 15 KHz, as previously described.'7 The random variability between repeated measurements was 7+2%. Brachial artery compliance (BAC) was evaluated according to the formula BAC=dV/dP=V/pPWJA, where dV is the change in volume, dP is the change in pressure, V is arterial volume, p is the blood density, and PWV is the brachioradial pulse wave velocity (determined as the time delay between the feet of simultaneously recorded pulse waves).17
Statistical Methods
Data are presented as mean+SEM. Distribution of the data was assessed by the Bartlett test. Twofactor analysis of variance (ANOVA) (factoring for family history status and time) for repeated measures was used to analyze the responses to saline infusion and was followed by a posteriori comparisons of the responses. Baseline data of the hypertensive and normotensive groups were compared by one-way ANOVA followed by simultaneous multiple comparisons using the modified t test; the Bonferroni method was used for adjusting the significance level. Two-way ANOVA with Dunnett's correction was used for determining significant differences within groups. x2 analysis was used for comparisons of descriptive parameters. Fisher's exact test was used for the analysis of contingency tables. Pearson's correlation coefficients were used to examine relations among variables.
Results

Hypertensive Subgroups
Clinical characteristics of the two hypertensive subgroups (FV+ and FV-) are outlined in Tables 1  and 2 . As shown in Table 1 , the two subgroups were comparable with respect to age, weight, sex distribution, blood pressure, parental history and duration of hypertension, known cardiovascular risk factors (cigarette smoking and total cholesterol and HDL-cholesterol concentrations), and target organ damage indicators (left ventricular mass index, brachial artery compliance, creatinine concentration, and urinary protein excretion). Table 2 shows that baseline levels of the hormonal parameters and urinary electrolyte excretion were similar in the FV+ and FV subgroups. Despite these similarities, there were significant differences between the subgroups with respect to the responses of PRA, PA, and ANF to an acute saline load.
In both subgroups PRA progressively decreased during the saline load, reaching a nadir at 120 minutes (0.98+0.2 ng/ml/hr in FV-and 1.71+0.4 ng/ml/hr in FV+, p<O.Ol). As shown in Figure 1 , the absolute degree of PRA suppression was significantly smaller in the FV+ subgroup than in the FV-subgroup at both 60 and 120 minutes of saline load and after 60 minutes of The percentage of subjects suppressing PRA by at least 50% after 60 minutes of saline load (i.e., the level of suppression observed in normal subjects) was 85.7% in the FV-subgroup, whereas it was only 16.7% in the FV+ subgroup (p<0.001). At 120 minutes, 92.9% of the FV-subgroup and only 33.3% of the FV+ subgroup (p<0.001) suppressed PRA by at least 50% (Figure 2 ). family history was 13.14 (p<0.001) and differences between subgroups were significant (*) at 60 and 120 minutes.
As shown in the bottom panel of Figure 1 , the absolute increases of plasma ANF levels in response to the saline load were significantly smaller in the FV+ subgroup than in the FV-subgroup at both 60 (p<0.005) and 120 (p<0.005) minutes. The difference in the ANF response between the subgroups was not significant at 60 minutes of recovery. The peak ANF levels during the saline load were 102±+17 pg/ml in the FV-subgroup and 72±+14 pg/ml in the FV+ subgroup (p<O.O5). Consistent Suppression of the PA level by the saline load was significantly attenuated in the FV+ subgroup at 60 minutes (FV+=-89.4±+26 pg/ml versus FV =-190+ 43 pg/ml,p<O0.05), while it was not different in the two subgroups at 120 minutes (-179+±29 pg/ml versus -239+53 pg/ml, respectively) and after 60 minutes of recovery (-212+43 pg/ml versus -269+58 pg/ml, respectively). PNE concentrations did not change significantly during the saline load in either subgroup, and the changes from baseline were comparable at both 60 (FV-=-56±53 pg/ml versus FV+=-37+10 pg/ml) and 120 (FV-=-51+55 pg/ml versus FV+=-135+50 pg/ml) minutes.
With regard to renal sodium handling, urinary sodium excretion measured at baseline was comparable in the two subgroups (114±19 geq/min in FV-and 106±36 ,ueq/min in FV+; Figure 3, top) . Following saline infusion, all hypertensive subjects had a sustained increase in urinary sodium excretion. However, the natriuretic response was delayed in the FV+ subgroup. In fact, at 60 minutes urinary sodium excretion was significantly greater than baseline only in the FVsubgroup (555±+157 ,ueq/min), not in the FV+ subgroup (270±67 ,ueq/min, p<0.05). At 120 minutes (922±256 ,ueq/min in FV-versus 774±181 ,ueq/min in FV+) and during recovery (980±+176 versus 636±94 ,ueq/min), however, urinary sodium excretion in the subgroups was not significantly different.
Diastolic blood pressure was comparable at baseline in the two subgroups (Figure 3, bottom) . During the saline load, diastolic blood pressure responses did not differ between subgroups. However, diastolic blood pressure was significantly less than baseline at both 60 and 120 minutes only in the FV-subgroup, while it remained unchanged in the FV+ subgroup. Normal Subjects Baseline data of the control group of normal subjects are shown in Table 3 . The only significant differences between the normal and hypertensive groups were in the systolic and diastolic blood pressures (p<0.001). The hormonal responses induced by an acute saline load in the normal subjects are presented in Table 4 . Since baseline levels of these parameters were not uniform with those in the hypertensive subgroups, both absolute and percentage changes induced by the saline load are provided. 
Discussion
We divided 32 patients with essential hypertension into two subgroups on the basis of the presence or absence of a parental history of acute cardiac or cerebrovascular accidents. Our data demonstrate remarkable differences in the hormonal and renal responses to an acute saline load between the subjects with a family history positive for stroke or myocardial infarction (FV+) and those with a family history completely negative for vascular accidents (FV-). More specifically, in the FVW subjects the major physiological adjustments occurring in response to an acute saline load (i.e., suppression of PRA, PA, and ANF concentrations and increased urinary sodium excretion) were significantly smaller or delayed compared with those in the FV-subjects or normal individuals.
The abnormal response observed in the FV+ subjects could not be related to a more severe stage of hypertension or to a different degree of involvement of target organs in the two subgroups. In fact, both hypertensive subgroups included only relatively young patients with mild, uncomplicated hypertension. In addition, the two subgroups were largely comparable with regard to age, sex distribution, blood pressure, duration of hypertension, cardiovascular risk factors, renal function, target organ damage, and hormonal profile. Parental history of hypertension was also identical, thus suggesting that the incidence of cardiovascular accidents in the family was not due to an excess of hypertension or to a more severe form of hypertension in one subgroup. For these reasons, the reduced ability of the FV+ subjects to handle a sodium load can be interpreted as an independent abnormality not secondary to hypertension. Several features of the blunted response to a saline load observed in the FV+ subjects could be defined in our study.
First, the ability to suppress PRA in response to a saline load was reduced by about 50% at 60 minutes and 37% at 120 minutes compared with the FVsubjects. A reduction of PRA within the normal range (50%) was consistently observed in the FVsubjects but in only three FV + subjects. This suggests a pattern of two distinct populations rather than a continuum.
Our studies do not clarify the mechanisms underlying the blunted PRA response. It seems unlikely that there were differences in the baseline degree of volume depletion since both subgroups were maintained on the same intake of fluids and sodium and baseline PRA and PA concentrations were comparable. In addition, the possibility of different sympathetic responses in the two subgroups is minimized by the observation that the PNE responses were comparable. More likely, the reduced ability to suppress PRA in the FV+ subjects could be related to a different sensitivity to sodium loading to the macula densa or to the lower plasma ANF levels observed in this subgroup. This further hallmark of the response observed in the FV+ subjects could have, in fact, contributed to the blunted PRA suppression. Previous studies have reported that increases of circulating ANF levels as produced by exogenous infusion,18 immersion,19 or volume expansion20 are associated with PRA suppression. Our observation that the increments in ANF concentration and the decrements in PRA induced by a saline load were significantly correlated may indirectly support a modulatory role of endogenous ANF on renin release under these circumstances. Thus, it could be speculated that the failure to suppress PRA in response to acute saline loading, known to occur in some hypertensive patients,21,22 is related to the way in which the volume load is distributed and not to renal or renin responsiveness. A different distribution of volume load in the two subgroups may in fact explain the different ANF responses. Alternatively, the abnormal ANF response might also be related to an impairment of the relation between increases of blood volume and those of atrial pressure or wall stretch during saline infusion. In keeping with our findings, hyposecretion of ANF in response to a saline load has been reported in different rat models of genetic hypertension including stroke-prone SHR23 and prehypertensive Dahl salt-sensitive rats.24
A third feature of the response of the FV + subjects to a saline load was the altered suppression of the PA concentration. However, the PA response, unlike the PRA and ANF responses, appeared to be only delayed.
A fourth difference between the FV+ and FVsubjects was represented by the delayed urinary excretion of sodium observed in the FV+ subjects. In fact, at 60 minutes of saline load the rate of sodium excretion was twofold higher in the FV-subjects.
Our data do not provide direct evidence of causeeffect relations between the changes in PRA, PA concentration, and ANF concentration and those of urinary sodium excretion. Nonetheless, the blunted responses of PRA and ANF and the delayed PA suppression might have contributed to the delayed excretory response to sodium loading observed in the FV+ subjects.
Finally, a slight reduction in diastolic blood pressure during the saline load was observed in the FVsubjects, while in the FV+ subjects diastolic blood pressure did not decrease.
It is interesting at this point to observe that some of the characteristics of our hypertensive patients with a parental history of vascular accidents (FV +) are reminiscent of those observed in a subgroup of hypertensives unable to modulate renal vascular and adrenal responsiveness to angiotensin II and to acute or chronic sodium loads, who have been defined as nonmodulators.25 These latter patients show, as ours do, a reduction or a delay in PRA and PA suppression.22,2526 They also present a transient pressor or no blood pressure response to a saline infusion and have a reduced rate of sodium excretion. 26 The ANF concentration, which failed to increase adequately in our FV+ subjects in response to the saline load, was not measured in the nonmodulators. Although we did not assess whether our FV + hypertensive patients are nonmodulators, the illustrated similarities suggest such a hypothesis. In this view, a family history of vascular accidents, which was defined only in our study, may be a common denominator for these conditions and may link nonmodulating hypertension to premature cardiovascular disease.
Two important questions are raised by our study. The first is whether the blunted hormonal and renal adjustments to a saline load observed in the hypertensive patients with a family history of vascular accidents reflect an hereditary trait. In this regard, there is evidence that sodium handling is influenced by heredity and modified by a family history of hypertension.2728 In addition, the response to an acute or chronic sodium load is altered in nonmodulation, a condition that has been recently demonstrated to be a heritable trait in hypertension. 29 Finally, it has been recently shown in an experimental model of hypertensive rats genetically predisposed to stroke that the suppression of PRA by an acute or chronic salt load is blunted during the early phase of disease, when renal lesions are not present.630 It should also be noted that our FV+ subgroup included relatively young patients with mild, uncomplicated hypertension and a family history of vascular accidents studied under controlled dietary and environmental conditions. In view of these considerations, many potential clinical and environmental causes of the abnormalities described are excluded. Our study, however, cannot answer this question, and more specific investigations including the analysis of familial aggregation of these abnormalities will be necessary to further elucidate this aspect.
A second intriguing question is whether the blunted adaptation to a saline load observed in our FV4 subjects has a causal relation with a more rapid development of the disease or is predictive of vascular accidents. Although a long-term follow-up study will be required to define whether our FV+ patients will develop vascular lesions earlier than our FVsubjects, a more rapid progression of vascular lesions is indeed expected in patients with a family history of vascular accidents. In fact, a familial clustering of malignant hypertension due to genetic rather than environmental influences has been described.2 Furthermore, a history of relatively early death in a parent or sibling from a hypertensive cardiovascular complication significantly increases the chance of an accelerated progression of the hypertensive disease in patients with borderline or mild hypertension. 2 Similarly, it has been reported that a positive family history of heart attack is an independent factor predictive of death from cardiovascular and ischemic heart disease after adjusting for other risk factors.' In our study, age, sex distribution, blood pressure, cigarette smoking, body weight, and cholesterol and glucose levels were comparable in the two subgroups of hypertensive patients. Therefore, other factors may be involved in the development of vascular disease. In this regard, the abnormalities of hormonal and renal responses to a saline load observed in our hypertensive subjects with a parental history of premature cardiovascular accidents may play a role. However, the possibility that these abnormalities merely reflect a different adaptation to hypertension in the FV'+ hypertensive subjects should be considered. Studies in FV + and FV-normotensive subjects would be of great interest to define the possible pathogenetic role of the salt-regulating hormone abnormalities in the development of cardiovascular accidents. With regard to the blunted PRA suppression observed in our FV+ subjects, a role of the high renin/sodium phenotype as a potential cardiovascular risk factor for patients with essential hypertension has been proposed8 and recently confirmed in a much larger population. 31 The hypothesis that inappropriate or excessive activity of the renin-angiotensin system causes vascular injury is supported by a number of experimental observations.32-34 In addition, recent studies in a genetic model of malignant hypertension (stroke-prone SHR) demonstrated an inability to suppress PRA in response to an acute or chronic sodium load prior to the occurrence of established hypertension or renal lesions.6,30 Prevention of the progressive activation of the renin-angiotensin system by enalapril7 or potassium dietary supplements6 also reduced the number of vascular lesions, the incidence of stroke, and the death rate in these animals. This latter observation is consistent with the finding that converting enzyme inhibition restores most of the abnormalities observed in nonmodulator patients with essential hypertension. 35'36 
